Ankasa (Biotechnology) Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $6M
Latest Deal Amount
  • Investors
  • 6

Ankasa (Biotechnology) General Information

Description

Developer of novel protein-based therapies designed to improve tissue repair and regeneration. The company's therapies enhance the osteogenic properties of patient-derived stem cells used in reconstructive surgeries, provide safe and effective enhancement of bone formation, enabling patients to avail demonstrated superiority in terms of bone reformation over existing standards of care in various preclinical models.

Contact Information

Website
www.ankasaregenerativetherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
  • 11099 North Torrey Pines Road
  • Suite 290, La Jolla
  • San Diego, CA 92037
  • United States
+1 (858) 000-0000

Ankasa (Biotechnology) Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ankasa (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 13-Oct-2020 $6M 0000 Completed Generating Revenue
3. Grant 00.000 0000 Completed Generating Revenue
2. Accelerator/Incubator 01-Mar-2018 $19M Completed Generating Revenue
1. Early Stage VC (Series A) 30-Jul-2015 $19M $19M Completed Generating Revenue
To view Ankasa (Biotechnology)’s complete valuation and funding history, request access »

Ankasa (Biotechnology) Executive Team (4)

Name Title Board Seat Contact Info
Sanford Madigan Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Jill Helms Ph.D Co-Founder & Senior Advisor
Scott Burkette Co-Founder
Gloria Matthews Ph.D Chief Medical Officer
To view Ankasa (Biotechnology)’s complete executive team members history, request access »

Ankasa (Biotechnology) Board Members (3)

Name Representing Role Since
Andre Kobelt Ph.D Self Board Member 000 0000
Kevin Kinsella Avalon Ventures Board Member 000 0000
Sanford Madigan Ph.D Ankasa (Biotechnology) Co-Founder, Chief Executive Officer, President & Board Member 000 0000
To view Ankasa (Biotechnology)’s complete board members history, request access »

Ankasa (Biotechnology) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ankasa (Biotechnology) Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator Minority 000 0000 000000 0
Avalon Ventures Venture Capital Minority 000 0000 000000 0
Correlation Ventures Venture Capital Minority 000 0000 000000 0
Heraeus Holding Corporation Minority 000 0000 000000 0
Stanford University Venture Fund Other Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial